The urology devices market is a broad category and covers equipment that is used for treating numerous problems relating to the urological system. The urology devices market is used for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary and kidney stones, erectile dysfunction and urinary incontinence. Other markets explored include urological endoscopes, urodynamic equipment and nephrostomy devices. Check out our urology devices market reports below.
In 2020, the urological device market size in China was valued at nearly $540 million, with over 2.4 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach $605 million in 2026. Throughout this medical market research, we analyzed 49 urology companies
In 2020, the urological device market size in Japan was valued at $383 million, with over 540,000 urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.3% to reach $480 million in 2026. Throughout this medical market research, we analyzed 31 urology companies across
By 2020, the Brazilian urological device market size was valued at $663.6 million, with over 1.23 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 2.8% to reach $806 million in 2026. Throughout this medical market research, we analyzed 54 urology companies across
In 2020, the Australian urology market size was valued at nearly $72 million, with over 167,000 yearly urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3% to reach nearly $89 million in 2026. Throughout this medical market research, we analyzed 31 urology companies
The market for urological endoscopes experienced the highest level of growth in 2015. This segment will continue to demonstrate a higher level of growth throughout the forecast period. Compared to other segments in the total market, the endoscope market will grow at rates more than three times faster, with the exception of one. Growth will
Overall, the U.S. urology market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $3.8 billion. As the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing
Industry Trends In the U.S. urology market, the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs), coupled with the reimbursement cuts across the urology space, average selling prices are expected to remain under significant pressure, negatively impacting the future
Industry Trends Urinary catheters are hollow plastic or rubber tubes that are inserted into the urethra for the collection of urine for patients with urinary dysfunction. Intermittent catheters are used for short-term catheterization and are segmented into conventional, closed system and antimicrobial catheters. Foley catheters are generally used as long-term catheters and are retained by
Laser BPH treatment is a broad category of laser techniques that have been developed to treat benign prostate hyperplasia (BPH). Laser procedure options include photo-selective vaporization (PVP), holmium laser ablation (HoLAP), holmium laser resection (HoLRP), holmium laser enucleation (HoLEP), interstitial laser coagulation (ILC) and visual laser ablation (VLAP).
Brachytherapy is an outpatient procedure for the treatment of prostate cancer. In brachytherapy, a needle is inserted through the perineum and radioactive seeds are implanted into the prostate. Fluoroscopy and ultrasound are used to visualize the prostate gland for precise positioning of the needles. There are three types of LDR radioactive seeds: iodine-125, palladium-103 and cesium-131. These radioactive isotopes are left inside the prostate for up to several weeks and ultimately destroy tumor cells by damaging the cells DNA, diminishing their ability to repair and causing cell death. Because palladium isotopes have a shorter half-life than iodine isotopes, the radiation dosage is delivered over a shorter period of time. For the purposes of this analysis, only iodine seeds will be considered.
For an erection to occur, blood flows into the penis, which causes it to expand and stiffen; this is sparked by impulses from the brain to the genital nerves. Erectile dysfunction (ED) can be caused when these impulses are blocked, or the flow of blood to the penis is restricted. Chronic diseases such as diabetes, cardiovascular disease, atherosclerosis, kidney disease and multiple sclerosis can be common underlying causes. Certain medications, psychological factors and injuries can also be factors leading to ED.
Under normal circumstances urine travels between the kidneys and bladder through the ureters. When a blockage prevents this flow, ureteral stents are usually threaded into the ureter as a solution. In cases where this is not the best option, a nephrostomy tube can be used to maintain a passageway between the skin and renal pelvis to facilitate drainage. Without treatment, pressure would build within the urinary system and cause kidney damage. Blockage can result from tumors, kidney stones and pyonephrosis or the infection of the renal pelvis and collecting system.
There are numerous methods for treating and removing kidney and urinary stones. Treatments can be classified as either extracorporeal or endoscopic stone management procedures. Extracorporeal shock wave lithotripsy (ESWL) treatment uses an ultrasound device to fragment the stone until it is small enough to be passed through the urethra. This is a non-invasive outpatient procedure that generally takes one hour to complete and is performed under local anesthesia. Typically, ESWL is used for small- to medium-sized stones between 1/6 inch and one inch in size. On average, stones re-form in 20% of ESWL patients because fragments are not completely excreted. Complications associated with ESWL include blocked urine flow from fragments in the urinary tract, bleeding and urinary tract infection. In addition, ESWL is rarely used on cystine kidney stones because these do not break up easily.
Transurethral resection of the prostate (TURP) is the leading procedure to treat benign prostate hyperplasia (BPH). TURP is an interventional procedure that is performed under anesthesia in which a resectoscope is inserted through the urethra to remove obstructing prostate tissue. The procedure is nearly as effective as open prostatectomy, but has a lower risk of serious complications such as blood loss, incontinence and impotence.
The urinary catheter market is segmented into intermittent, Foley and male external catheters. Urinary catheters are hollow plastic or rubber tubes that are inserted into the urethra for the collection of urine for patients with urinary dysfunction. Intermittent catheters are used for short-term catheterization and include conventional, closed system and antimicrobial catheters. Foley catheters are generally used as long-term catheters and are retained by a balloon at the tip which is inflated with water. Foley catheters include those that are sold alone or those sold as trays; the corresponding market includes further segmentation between conventional and antimicrobial Foley catheters. Male external catheters are devices that fit over the penis and connect to a drainage bag.
Urological endoscopes are long, tube-like instruments used in a number of urological procedures to examine inside the body or perform minimally invasive surgery. Urological endoscopes include cystoscopes for endoscopy of the urinary bladder, ureteroscopes for examining the ureter, resectoscopes used in transurethral resection of the prostate (TURP) and nephroscopes used to examine the kidneys.